Delivery Order SPE2DR25D1109-SPE2DR26FFH6K
Award Date 12/9/25
Potential Completion Date 12/31/25
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Veklury (remdesivir) 100 mg vials, with a ceiling value of $5,010.48 and an ultimate completion date of December 1, 2025. This is a firm fixed-price delivery order awarded without set-aside designation, indicating competitive award based on the vendor's demonstrated capability to fulfill federal pharmaceutical procurement requirements. The place of performance is...
- The Defense Logistics Agency awarded a $2,377.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), an antiviral medication used in medical treatment protocols. The contract, which is a child award under a larger indefinite delivery vehicle, was competitively awarded without set-aside designation and is scheduled for completion by May 12, 2025. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,754.64 for 100 mg vials of Veklury on September 12, 2025, with an ultimate completion date of October 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Veklury (remdesivir) is an antiviral medication used in the treatment of certain serious viral infections and represents part of...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $5,010.48 firm fixed price delivery order for 100 mg vials of Veklury (remdesivir), a broad-spectrum antiviral medication, with a completion date of December 8, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Veklury (remdesivir) 100 mg vials valued at $15,848.80 under a firm fixed-price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,962.20 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), a broad-spectrum antiviral medication. This firm fixed-price delivery order, issued on June 3, 2025, with an ultimate completion date of June 25, 2025, represents a non-competitive award under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $12,526.20 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), an antiviral medication. This firm fixed-price delivery order, issued on December 4, 2025, with completion expected by December 26, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through competitive procedures with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $5,943.30 to AmerisourceBergen Drug Corp for 100 mg vials of Veklury (remdesivir), an antiviral medication used in treating severe COVID-19 infections. This firm fixed-price delivery order, awarded on August 26, 2025, represents a non-competitive child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 through December 2026....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 mg vials of the antiviral drug Veklury (Remdesivir). The $13,618.40 contract has an ultimate completion date of April 17, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15,848.80 in Veklury 100 mg vials under a firm fixed-price contract with an ultimate completion date of September 29, 2025. This non-set-aside award was issued competitively on September 8, 2025, with performance conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Veklury (remdesivir) is an antiviral medication used primarily for treating COVID-19 infections, representing...